Error in Table
In the original publication [1], there was a mistake in Table 2 as published. In the table, we quoted the baseline of blood parameter-ALT of the L. paracasei TISTR 2593 group which was at “25.85 ± 418.66 U/L”.
The corrected blood parameter appears below.
ALT on the baseline of the L. paracasei TISTR 2593 group was “25.85 ± 18.66 U/L”.
Text Correction
There was an error in the original publication in Materials and Methods and Discussion [1]. We stated that the dose of “L. paracasei TISTR 2593” was at “1.05 × 1010 CFU/g”.
A correction has been made to Materials and Methods, Section 2.2., paragraph 2.
The correct dose of L. paracasei TISTR 2593 is “1.05 × 109 CFU/g”.
A correction has been made to Discussion, paragraphs 1 and 2.
The correct dose of L. paracasei TISTR 2593 is “1.05 × 109 CFU/g”.
Footnotes
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.
Reference
- 1.Khongrum J., Yingthongchai P., Boonyapranai K., Wongtanasarasin W., Aobchey P., Tateing S., Prachansuwan A., Sitdhipol J., Niwasabutra K., Thaveethaptaikul P., et al. Safety and Effects of Lactobacillus paracasei TISTR 2593 Supplementation on Improving Cholesterol Metabolism and Atherosclerosis-Related Parameters in Subjects with Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. Nutrients. 2023;15:661. doi: 10.3390/nu15030661. [DOI] [PMC free article] [PubMed] [Google Scholar]